HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A comparison of covered vs bare expandable stents for the treatment of aortoiliac occlusive disease.

AbstractOBJECTIVE:
This trial was conducted to determine if covered stents offer a patency advantage over bare-metal stents in the treatment of aortoiliac arterial occlusive disease.
METHODS:
The Covered Versus Balloon Expandable Stent Trial (COBEST), a prospective, multicenter, randomized controlled trial, was performed involving 168 iliac arteries in 125 patients with severe aortoiliac occlusive disease who were randomly assigned to receive a covered balloon-expandable stent or bare-metal stent. Patient demographic data, clinical signs and symptoms, TransAtlantic Inter-Society Consensus (TASC) classification, and preprocedure and postprocedure ankle-brachial index measurements were recorded. The primary end points included freedom from binary restenosis and stent occlusion of the treated area, as determined by ultrasound imaging or quantitative visual angiography, or both. Postprocedural follow-up was at 1, 6, 12, and 18 months.
RESULTS:
Aortoiliac lesions treated with a covered stent were significantly more likely to remain free from binary restenosis than those that were treated with a bare-metal stent (hazard ratio [HR], 0.35; 95% confidence interval (CI), 0.15-0.82; P = .02). Freedom from occlusion was also higher in lesions treated with covered stents than in those treated with a bare-metal stent (HR, 0.28; 95% CI, 0.07-1.09); however, this did not reach statistical significance (P = .07). Subgroup analyses demonstrated a significant difference in freedom from binary restenosis for covered stents in TASC C and D lesions compared with a bare stent (HR, 0.136; 95% CI, 0.042-0.442). This difference was not demonstrated for TASC B lesions (HR, 0.748; 95% CI, 0.235-2.386).
CONCLUSIONS:
COBEST demonstrates covered and bare-metal stents produce similar and acceptable results for TASC B lesions. However, covered stents perform better for TASC C and D lesions than bare stents in longer-term patency and clinical outcome.
AuthorsBibombe P Mwipatayi, Shannon Thomas, Jackie Wong, Suzanna E L Temple, Vikram Vijayan, Mark Jackson, Sally A Burrows, Covered Versus Balloon Expandable Stent Trial (COBEST) Co-investigators
JournalJournal of vascular surgery (J Vasc Surg) Vol. 54 Issue 6 Pg. 1561-70 (Dec 2011) ISSN: 1097-6809 [Electronic] United States
PMID21906903 (Publication Type: Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial)
CopyrightCrown Copyright © 2011. Published by Mosby, Inc. All rights reserved.
Chemical References
  • Coated Materials, Biocompatible
  • Metals
  • Polytetrafluoroethylene
Topics
  • Aged
  • Angioplasty, Balloon
  • Aorta
  • Arterial Occlusive Diseases (therapy)
  • Coated Materials, Biocompatible
  • Cohort Studies
  • Female
  • Humans
  • Iliac Artery
  • Male
  • Metals
  • Middle Aged
  • Polytetrafluoroethylene
  • Prosthesis Design
  • Stents
  • Treatment Outcome
  • Vascular Patency

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: